- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefTM
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request A Presentation
- ADPKD Simulator
- Patient Resources
- Log In
- Join
- Log Out
- Account
Archives
Dietary Factors & Polycystic Kidney Disease (PKD): Disease Progression
This presentation, Dietary Factors & Polycystic Kidney Disease (PKD): Disease Progression, reviews practical guidance for diet and PKD and focuses on the preclinical and clinical data on the role of body mass index, caloric intake, cholesterol, and caffeine on PKD progression. In this presentation the impact of these dietary factors on the pathophysiology of PKD and outcomes will be discussed.
*Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Featured Speakers
Jill A Green, PhD
Nephrology Clinical & Scientific Director-
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Jill A Green, PhD, is a Senior Medical Science Liaison in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.
Dr Green has been a proud member of the PKD Foundation – Columbus, OH chapter for over 12 years where she has been active in fundraising and advocacy efforts.
Kaitlin Dehlin, PhD, RD
Nephrology Medical Science Liaison-
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Kaitlin Dehlin, PhD, RD earned her doctorate from West Virginia University in Animal and Nutritional Sciences. Her doctoral work examined various dietary interventions to attenuate disease progression in a preclinical rat model of polycystic kidney disease. Prior to that, Dr. Dehlin earned a master’s degree and worked clinically as a Registered Dietitian.
Since the completion of her doctorate in 2014, Dr. Dehlin joined Mead Johnson Nutrition and worked on various products and clinical trials. She joined Otsuka in 2018 as a Medical Science Liaison. During her time at Otsuka, she has built relationships with key opinion leaders, assisted in resource development, and worked with several clinical trial sites.
Location
Online via NephU.org
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2023 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.